Proteomic analysis uncovers distinct signatures of bacterial-viral coinfections in cystic fibrosis cells

A. Endres (Frankfurt am Main, Germany), P. Kastl (Lyngby, Denmark), H. Boland (Frankfurt am Main, Germany), C. Hügel (Frankfurt am Main, Germany), K. Kalogeropoulos (Lyngby, Denmark), P. Braubach (Hanover, Germany), D. Jonigk (Hanover, Germany), M. Hogardt (Frankfurt am Main, Germany), G. Rohde (Frankfurt am Main, Germany), U. Auf Dem Keller (Lyngby, Denmark), C. Bellinghausen (Frankfurt am Main, Germany)

Source: Virtual Congress 2021 – Adult cystic fibrosis
Session: Adult cystic fibrosis
Session type: Oral Presentation
Number: 1495

Congress or journal article abstractWebcastSlide presentation

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
A. Endres (Frankfurt am Main, Germany), P. Kastl (Lyngby, Denmark), H. Boland (Frankfurt am Main, Germany), C. Hügel (Frankfurt am Main, Germany), K. Kalogeropoulos (Lyngby, Denmark), P. Braubach (Hanover, Germany), D. Jonigk (Hanover, Germany), M. Hogardt (Frankfurt am Main, Germany), G. Rohde (Frankfurt am Main, Germany), U. Auf Dem Keller (Lyngby, Denmark), C. Bellinghausen (Frankfurt am Main, Germany). Proteomic analysis uncovers distinct signatures of bacterial-viral coinfections in cystic fibrosis cells. 1495

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Proteomic analysis of sputum from adults with cystic fibrosis and COPD: identification of potential biomarkers for disease monitoring
Source: Eur Respir J 2006; 28: Suppl. 50, 152s
Year: 2006

Phenotypic and genotypic profiles of microorganisms isolated from children with cystic fibrosis
Source: Eur Respir J 2003; 22: Suppl. 45, 503s
Year: 2003

Metabolomic biomarkers predictive of early structural lung disease in cystic fibrosis
Source: Eur Respir J 2016; 48: 1612-1621
Year: 2016



Transcriptome profiling reveals the complexity of pirfenidone effects in idiopathic pulmonary fibrosis
Source: Eur Respir J, 52 (5) 1800564; 10.1183/13993003.00564-2018
Year: 2018



Unsupervised phenotypic clustering for determining clinical status in children with cystic fibrosis
Source: Eur Respir J, 58 (2) 2002881; 10.1183/13993003.02881-2020
Year: 2021



Proteomic and genomic profiling to identify pathogenic mechanisms of inflammation, proteolysis and wasting in a murine COPD model
Source: Eur Respir J 2004; 24: Suppl. 48, 104s
Year: 2004

RNA-seq analysis does not substantiate a causative link between herpes virus infection and IPF
Source: International Congress 2015 – IPF pathogenesis
Year: 2015


Molecular detection of complex microbial communities in sputa of patients with cystic fibrosis and non cystic fibrosis bronchiectasis
Source: Annual Congress 2010 - Cystic fibrosis: lung disease infection and more
Year: 2010

iTRAQ-based proteomic analysis reveals mitochondrial 'damage'-associated molecular patterns are involved in pulmonary inflammation in Lypopolysaccharide-induced acute lung injury
Source: International Congress 2018 – Role of microbial exposure and inflammation in lung injury
Year: 2018

The identification of bacterial strains in specimens of adult cystic fibrosis patients
Source: Eur Respir J 2004; 24: Suppl. 48, 49s
Year: 2004

Comparative proteome analysis of lung tissue from patients with idiopathic pulmonary fibrosis, non-specific interstitial pneumonia and human donor lungs
Source: Annual Congress 2008 - Management of idiopathic pulmonary fibrosis: what can we learn from the pathophysiology?
Year: 2008

Proteomics characterisation of nasal epithelial cells in cystic fibrosis
Source: Annual Congress 2009 - New results in molecular pathology and functional genomics of non-neoplastic lung diseases
Year: 2009


Ivacaftor/lumacaftor changes the lung microbiome and metabolome in cystic fibrosis patients
Source: Virtual Congress 2020 – Advances in cystic fibrosis: from microbiome to MRI
Year: 2020




Current concepts: host–pathogen interactions in cystic fibrosis airways disease
Source: Eur Respir Rev 2014; 23: 320-332
Year: 2014



Immunophenotyping and genic re-arrangement analysis in lymphocytic/lymphoproliferative disorders of the lungs
Source: Annual Congress 2007 - Role of genomics and biological tools in the work-up of interstitial lung disease
Year: 2007



Whole metagenome shotgun sequencing analysis of microbiome of cystic fibrosis- and COPD patients
Source: International Congress 2014 – Cystic fibrosis: genotypes, inflammation and microbiology
Year: 2014

Histopathologic and immunohistochemical characterization of antioxidants profiles in different compartments in severe COPD
Source: Annual Congress 2013 –Translational studies in chronic lung diseases: from bedside to bench
Year: 2013

Proteomic profile of cystic fibrosis sputum cells in adults chronically infected with Pseudomonas aeruginosa
Source: Eur Respir J, 50 (1) 1601569; 10.1183/13993003.01569-2016
Year: 2017



Genetic characterization of cystic fibrosis patients in Portugal
Source: Annual Congress 2013 –Cystic fibrosis: clinical problems, genetics and microbiology in children
Year: 2013